Answers are grounded in this paper and cite their sources.
Intravesical gemcitabine and docetaxel therapy is well tolerated and effective, providing a durable response in patients with recurrent nonmuscle invasive bladder cancer after bacillus Calmette-Guérin therapy. Further prospective study is warranted.
No takes yet. Share an insight, caveat, or question.
Steinberg et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: